DENNEWILL JAMES ROBERT JR. enters SPYGLASS PHARMA, INC. with 96.02K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/5/2026ACC: 0002106895-26-000002
Officer· Chief Operating Officer
Since Feb 2026
96.02K
Baseline shares
100% direct
96.02K
Direct ownership
1 position
169K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned96.02K
Total
96.02K direct96.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 96.02K | Direct |
| Total | 96.02K | 96.02K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
54.74K
Shares owned
N/A
Exercise price
7.11
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
35.76K
Shares owned
N/A
Exercise price
2.87
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
78.49K
Shares owned
N/A
Exercise price
2.18
Expiration
—
Exercise window
—
Total
Underlying
169K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 7.11 | — | — | 54.74K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 2.87 | — | — | 35.76K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 2.18 | — | — | 78.49K | N/A |
| Total | 169K | 0.00 | ||||